However, pre-treatment with N-acetyl-L-cysteine (NAC – the ROS inhibitor) before BC and pollen stimulation reduced the relative level of ROS, mRNA expression and protein levels of NLRP3 and IL-1β. This evidence concerns the gene NLRP3 and breast cancer.